Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guarneri

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Biological Psychiatry|July 21, 2000
H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patientsE Sacchetti, L Guarneri, D Bravi
Lancet (London, England)|July 9, 1994
Are SSRI antidepressants a clinically homogeneous class of compounds?E Sacchetti, G Conte, L Guarneri
Journal of Pharmacological and Toxicological Methods|January 5, 2002
Influence of pump compliance (peristaltic vs. infusion) on urodynamic measurement during cystometry in conscious ratsC Velasco, L Guarneri, A Leonardi, et al.
Pharmacological Research|October 1, 1991
Effects of oxybutynin, terodiline, and nifedipine on the cystometrogram in conscious rats with infravesical outflow obstructionL Guarneri, M Ibba, P Angelico, et al.
BJU International|June 26, 2003
Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstructionC Velasco, L Guarneri, A Leonardi, et al.
The Journal of Pharmacy and Pharmacology|August 24, 1999
Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissuesP Angelico, L Guarneri, A Leonardi, et al.
Journal of Pharmacological and Toxicological Methods|March 1, 1992
In vivo effects of different antispasmodic drugs on the rat bladder contractions induced by topically applied KClP Angelico, L Guarneri, B Fredella, et al.
Arzneimittel-Forschung|April 1, 1975
Pharmacological properties of n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine, a new non-anticholinergic gastric antisecretory agentA Bianchetti, L Guarneri, L M Biraschi, et al.
Arzneimittel-Forschung|January 1, 1977
Pharmacology of halopredone acetate, a new topical antiinflammatory steroidA Bianchetti, G Bossoni, L Guarneri, et al.
The American Journal of Psychiatry|November 1, 1996
Reducing the "revolving door" phenomenonG Conte, R Ferrari, L Guarneri, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|July 21, 2000
H(2) antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patientsE Sacchetti, L Guarneri, D Bravi
Lancet (London, England)|July 9, 1994
Are SSRI antidepressants a clinically homogeneous class of compounds?E Sacchetti, G Conte, L Guarneri
Journal of Pharmacological and Toxicological Methods|January 5, 2002
Influence of pump compliance (peristaltic vs. infusion) on urodynamic measurement during cystometry in conscious ratsC Velasco, L Guarneri, A Leonardi, et al.
Pharmacological Research|October 1, 1991
Effects of oxybutynin, terodiline, and nifedipine on the cystometrogram in conscious rats with infravesical outflow obstructionL Guarneri, M Ibba, P Angelico, et al.
BJU International|June 26, 2003
Effects of intravenous and infravesical administration of suramin, terazosin and BMY 7378 on bladder instability in conscious rats with bladder outlet obstructionC Velasco, L Guarneri, A Leonardi, et al.
The Journal of Pharmacy and Pharmacology|August 24, 1999
Vascular-selective effect of lercanidipine and other 1,4-dihydropyridines in isolated rabbit tissuesP Angelico, L Guarneri, A Leonardi, et al.
Journal of Pharmacological and Toxicological Methods|March 1, 1992
In vivo effects of different antispasmodic drugs on the rat bladder contractions induced by topically applied KClP Angelico, L Guarneri, B Fredella, et al.
Arzneimittel-Forschung|April 1, 1975
Pharmacological properties of n1-piperonyl-n4-3,7,11-trimethyl-2,6,10-dodecatrienyl-piperazine, a new non-anticholinergic gastric antisecretory agentA Bianchetti, L Guarneri, L M Biraschi, et al.
Arzneimittel-Forschung|January 1, 1977
Pharmacology of halopredone acetate, a new topical antiinflammatory steroidA Bianchetti, G Bossoni, L Guarneri, et al.
The American Journal of Psychiatry|November 1, 1996
Reducing the "revolving door" phenomenonG Conte, R Ferrari, L Guarneri, et al.
Pageof 4